FDA Inspection 807963 — Apozeal Pharmaceuticals Inc.

Apozeal Pharmaceuticals Inc. — FEI 3004536846

The FDA completed an inspection of Apozeal Pharmaceuticals Inc. on Nov 21, 2012 in Levittown, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 21, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Levittown, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.